Investment Report of China Medical Industry, 2000-2008
  • Jul/2008
  • Hard Copy
  • USD $2,300
  • Pages:126
  • Single User License
    (PDF Unprintable)       
  • USD $2,500
  • Code: FW004
  • Enterprise-wide License
    (PDF Printable & Editable)       
  • USD $3,800
  • Hard Copy + Single User License
  • USD $2,500

China is the largest country in the world in terms of population. Its population of 1.3 billion people provides a huge market for the development of China's medical service industry. The existing medical resources are far from being able to satisfy people's demand, which results in the problems to be difficult and expensive to see a doctor. However, China's non-public medical service industry is underdeveloped seriously. So China has put forward the ideas to develop medical and health service system by actively introducing non-public funds, which provides a great opportunity for the development of China's non-public medical service industry.

From Jan. to Nov. 2007, the total industrial output value of China's medical instrument and apparatus manufacturing industry hit CNY51.446 billion, up 21.42% against the same period of the previous year, while the accumulated sales revenue and accumulated profit reached CNY49.32 billion and CNY5.26 billion, up 22.17% and 42.51% year on year respectively. In the next few years, China will surpass Japan and become the second largest medical instrument market in the world. The total output value of China's medical instruments and apparatus industry will reach CNY100 billion in 2010, taking up 5% share in the world's medical instruments and apparatus market.

This report makes an in-depth analysis on all investment projects financed by 18 listed companies, covering medical apparatus producers, medical service providers and pharmaceutical producers with investment in medical instruments, from 2000 to 2008 and also makes summary of investment trends of China's medical industry as well as investment features and investment trends of the listed companies.

The following chart shows that Shanghai has the biggest investment in medical projects by taking up 22.72% share of the national total, followed by Hubei province, Jiangxi province, Beijing and Zhejiang province.

Investment Distribution of China Listed Medical Companies (by Region), 2000-1H2008


Resource: ResearchInChina

Among the 18 listed companies, Shanghai Pharmaceutical Co. Ltd. ranks first in terms of investment amount from the year of 2000 to the first half of 2008 with a total amount of CNY2.55 billion, followed by Wuhan Humanwell Hi-tech Industry Co., Ltd. and Chengzhi Shareholding Co., Ltd.

Top 10 Companies in Terms of Investment, 2000-1H2008

Resource: ResearchInChina

This report makes an in-depth analysis on all investment projects financed by the 18 listed companies. For example, Shanghai Pharmaceutical Co., Ltd. (600849) is referred in this report.

Investment Distribution of Shanghai Pharmaceutical Co. (by Sector), 2000-2008


Resource: ResearchInChina


Investment of Shanghai Pharmaceutical Co., 2001-2007Year Investment Amount (CNY million)


Investment Features of Shanghai Pharmaceutical Co., Ltd

  •  Main Business: production, distribution and retail of traditional Chinese medicine and western medicine; diversification direction: pharmaceutical logistics industry.
  • The company has kept a high investment amount for many years. Its investment hit CNY625 million in 2004, which is the highest record of this company. In the past four years, its investment was mainly financed by non fund raising. Its investment is concentrated in East China.
  • The company is one of the three giants in China's pharmaceutical distribution industry. Medicine distribution is its highlight, covering more than 3,900 hospitals across China with sales of more than CNY9 billion. With the help of its strategy of international development, the company together with SUZUKEN Co., Ltd., a world leader in pharmaceutical distribution, has set up a joint venture engaged in pharmaceutical distribution. It has also signed OEM agreement with American Perrigo Company (NASDAQ: PRGO) regarding seven varieties of products and the commitment of 2.1 billion pieces a year, which is hopeful to reach three billion pieces annually. As for pharmaceutical logistics, the company has built a logistics center with an annual throughput of CNY15 billion.

Note: When you purchase this report, we can update the data to the most recent quarter.

1. Investment Direction of Medical Apparatus & Medical Service Industry 
1.1 Overview of the industry
1.2 Investment Features
1.3 Development Trend

2. Investment Direction of Listed Medical Service Companies
2.1 Investment Projects of Chengzhi Shareholding Co., Ltd. 
2.1.1 Investment Direction
2.1.2 Investment Features
2.2 Investment Projects of Chang An Information Industry (Group) Co., Ltd. 
2.2.1 Investment Direction
2.2.2 Investment Features
2.3 Investment Projects of Beijing Tongche Medical Investment Co., Ltd.
2.3.1 Investment Direction
2.3.2 Investment Features

3. Investment Direction of Listed Medical Instrument Companies
3.1 Investment Projects of Shandong Pharmaceutical Glass Co., Ltd.
3.1.1 Investment Direction
3.1.2 Investment Features
3.2 Investment Projects of Suzhou Well Technology Co., Ltd. 
3.2.1 Investment Direction
3.2.2 Investment Features
3.3 Investment Projects of Beijing Wandong Medical Equipment Co., Ltd.
3.3.1 Investment Direction
3.3.2 Investment Features
3.4 Investment Projects of Shandong Shinva Medical Instrument Co., Ltd. 
3.4.1 Investment Direction
3.4.2 Investment Features
3.5 Investment Projects of Leading S&T Co., Ltd. 
3.5.1 Investment Direction
3.5.2 Investment Features
3.6 Investment Projects of Wuhan Humanwell Hi-tech Industry Co., Ltd. 
3.6.1 Investment Direction
3.6.2 Investment Features
3.7 Investment Projects of Yuyue Medical Equipment Co., Ltd. 
3.7.1 Investment Direction
3.7.2 Investment Features

4. Investment Direction of Listed Pharmaceutical Companies with Investment in Medical Instruments
4.1 Investment Projects of Shanghai Pharmaceutical Co., Ltd.
4.1.1 Investment Direction
4.1.2 Investment Features
4.2 Investment Projects of Zhejiang Zhenyuan Co., Ltd.
4.2.1 Investment Direction
4.2.2 Investment Features
4.3 Investment Projects of Accord Pharmaceutical Co., Ltd.
4.3.1 Investment Direction
4.3.2 Investment Features
4.4 Investment Projects of China National Medicines Corporation Ltd.
4.4.1 Investment Direction
4.4.2 Investment Features
4.5 Investment Projects of Shanghai No.1 Pharmacy Co., Ltd.
4.5.1 Investment Direction
4.5.2 Investment Features
4.6 Investment Projects of Nanjing Pharmaceutical Co., Ltd.
4.6.1 Investment Direction
4.6.2 Investment Features
4.7 Investment Projects of Chongqing Tongjunge Pharmaceutical Factory Co., Ltd.
4.7.1 Investment Direction
4.7.2 Investment Features
4.8 Investment Projects of Hangzhou Huadong Medicine Group Co., Ltd.
4.8.1 Investment Direction
4.8.2 Investment Features
Annual Investment of China Listed Medical Companies, 2000-2008
Investment Distribution of China Listed Medical Firms (by region), 2000-1H2008
Top 10 Regions in Terms of Investment of China Listed Medical Firms, 2000-2008
Investment Distribution of China Listed Medical Firms (by Region), 2000-1H2008
Top 10 Companies in Terms of Investment (by Investment Purpose), 2000-2008
Top 10 Firms in Terms of Investment Distribution (by Purpose), 2000-1H2008
Investment of China Listed Medical Firms by Segmented Industry, 2000-2008
Investment Distribution of Listed Firms by Segmented Industry, 2000-1H2008
Top 10 Companies in Terms of Investment, 2000-1H2008
Investment by Non Fund Raising of China Listed Medical Firms, 1Q2006-2Q2008
Investment by Non Fund Raising of Listed Firms by Region, 1Q2006-2Q2008
Top 5 Regions in Terms of Non Fund Raising Investment, 1Q2006-2Q2008
Top 5 Companies in Terms of Non Fund Raising Investment, 1Q2006-2Q2008
Top 5 Firms in Terms of Non Fund Raising Investment (by Segmented Industry), 
Annual Investment of Chengzhi Shareholding Co., Ltd., 2000-2008 
Chengzhi Investment Distribution by Region, 2000-2008
Chengzhi Investment Distribution by Investment Purpose, 2000-2008
Chengzhi Investment by Main Investment Purpose, 2000-2008
Chengzhi Investment Distribution by Segmented Industry, 2000-2008
Chengzhi Investment by Main Segmented Industry, 2000-2008
Chengzhi Main Investment Projects, 2000-2008
Chengzhi Latest Investment Projects, 2000-2008
Chengzhi Main M&A Projects, 2000-2008
Annual Investment of Chang An Information Industry (Group) Co., 2000-2008
Chang An Investment Distribution by Region, 2000-2008
Chang An Investment Distribution by Investment Purpose, 2000-2008
Chang An Investment by Main Investment Purpose, 2000-2008
Chang An Investment Distribution by Segmented Industry, 2000-2008
Chang An Investment by Main Segment Industry, 2000-2008
Chang An Main Investment Projects, 2000-2008
Chang An Latest Investment Projects, 2000-2008
Chang An Main M&A Projects, 2000-2008
Annual Investment of Beijing Tongche Medical Investment Co., 2000-2008
Beijing Tongche Investment Distribution by Region, 2000-2008
Beijing Tongche Investment Distribution by Investment Purpose, 2000-2008
Beijing Tongche Investment by Main Investment Purpose, 2000-2008
Beijing Tongche Investment Distribution by Segmented Industry, 2000-2008
Beijing Tongche Investment by Main Segmented Industry, 2000-2008
Beijing Tongche Main Investment Projects, 2000-2008
Beijing Tongche Latest Investment Projects, 2000-2008
Beijing Tongche Main M&A Projects, 2000-2008
Annual Investment of Shandong Pharmaceutical Glass Co., Ltd., 2000-2008
SPGC Investment Distribution by Region, 2000-2008
SPGC Investment Distribution by Investment Purpose, 2000-2008
SPGC Investment by Main Investment Purpose, 2000-2008
SPGC Investment Distribution by Segmented Industry, 2000-2008
SPGC Investment by Main Segmented Industry, 2000-2008
SPGC Main Investment Projects, 2000-2008
SPGC Latest Investment Projects, 2000-2008
SPGC Main M&A Projects, 2000-2008
Annual Investment of Suzhou Well Technology Co., Ltd., 2000-2008
Suzhou Well Investment Distribution by Region, 2000-2008
Suzhou Well Investment Distribution by Investment Purpose, 2000-2008
Suzhou Well Investment by Main Investment Purpose, 2000-2008
Suzhou Well Investment Distribution by Segmented Industry, 2000-2008
Suzhou Well Investment by Main Segmented Industry, 2000-2008
Suzhou Well Main Investment Projects, 2000-2008
Suzhou Well Latest Investment Projects, 2000-2008
Suzhou Well Main M&A Projects, 2000-2008
Annual Investment of Beijing Wandong Medical Equipment Co., Ltd., 2000-2008
Wandong Medical Investment Distribution by Region, 2000-2008
Wandong Medical Investment Distribution by Investment Purpose, 2000-2008
Wandong Medical Investment by Main Investment Purpose, 2000-2008
Wandong Medical Investment Distribution by Segmented Industry, 2000-2008
Wandong Medical Investment by Main Segmented Industry, 2000-2008
Wandong Medical Main Investment Projects, 2000-2008
Wandong Medical Latest Investment Projects, 2000-2008
Wandong Medical Main M&A Projects, 2000-2008
Annual Investment of Shandong Shinva Medical Instrument Co., Ltd., 2000-2008
Shinva Medical Investment Distribution by Region, 2000-2008
Shinva Medical Investment Distribution by Investment Purpose, 2000-2008
Shinva Medical Investment by Main Investment Purpose, 2000-2008
Shinva Medical Investment Distribution by Segmented Industry, 2000-2008
Shinva Medical Investment by Main Segmented Industry, 2000-2008
Shinva Medical Main Investment Projects, 2000-2008
Shinva Medical Latest Investment Projects, 2000-2008
Shinva Medical Main M&A Projects, 2000-2008
Annual Investment of Leading S&T Co., Ltd., 2000-2008
Leading S&T Investment Distribution by Region, 2000-2008
Leading S&T Investment Distribution by Investment Purpose, 2000-2008
Leading S&T Investment by Main Investment Purpose, 2000-2008
Leading S&T Investment Distribution by Segmented Industry, 2000-2008
Leading S&T Investment by Main Segmented Industry, 2000-2008
Leading S&T Main Investment Projects, 2000-2008
Leading S&T Latest Investment Projects, 2000-2008
Leading S&T Main M&A Projects, 2000-2008

China Interventional Cardiovascular Device Industry Report,2014-2017

The prevalence of cardiovascular disease in China impacted by accelerated aging of population and changes in consumption concept, dietary habit, way of working and other lifestyles has been growing ye...

China PTCA Balloon Market Investment Report, 2014-2016

PTCA balloon, as a indispensable medical device in percutaneous coronary intervention (PCI), serves not only as a delivery system for stent, but also as a device for pre-/post-stent dilatations. There...

China Orthopedic Instrument Industry Report, 2014-2017

Benefiting from accelerated aging population and rising proportion of reimbursement for medical expenses, the Chinese orthopedic instrument market demand has been effectively released, with its scale ...

China Hospital Development and Investment Report, 2014-2017

China hospital industry has been developing quickly in recent years, thanks to the market demand stimulus and steady progress in health care reform. The number of Chinese hospitals grew at a CAGR of 6...

China Diagnostic Reagent Industry Report, 2013-2016

With the accelerated aging of the Chinese population, the increase of personal health expenditure as well as the improved medical care facilities and government health care system, China diagnostic re...

China Hemodialysis Equipment Import and Export Report, 2013-2016

Hemodialysis equipment is the most widely used treatment apparatus in blood purification, primarily targeting patients with acute or chronic renal failure.The Chinese hemodialysis equipment market sho...

Global and China Hemodialysis Industry Report, 2013-2016

Hemodialysis, also known as artificial kidney, is a type of blood purification technology, primarily applicable to the treatment of patients with rental failure. In 2013, the global number of patient...

China Portable Medical Equipment Industry Report, 2013-2016

With the synergy of favorable policies, improvement in living standards and healthcare awareness raising, China’s portable medical device industry has shown rapid development in recent years, with mar...

China Medical Informatization Industry Report,2013-2016

Under the impetus of multiple favorable policies and market demand, China's medical informatization industry has entered a rapid development stage in recent years. As of the first half of 2013, manage...

China Aged Care Industry Report, 2013-2016

Currently, China has entered the accelerated aging period. China’s population aged 65 and above reached 131.61 million in 2013, accounting for 9.7% of total population; and the proportion will rise to...

China Pharmaceutical Equipment Industry Report, 2013-2016

After decades of development, China has become a major producer of pharmaceutical equipment in the world. Since 2010, affected by the new GMP certification and other factors, the revenue and total pro...

China Dental Industry Report, 2013-2016

The dental industry refers to medical industrial chain on the basis of oral medical consumption, consisting mainly of dental appliances (equipments and consumables), dental medical services, etc. with...

China Medical Monitor Industry Report, 2013-2015

In 2007-2011, the Chinese medical monitor market size rose from RMB1.16 billion to RMB3.08 billion at a CAGR of 27.8%. In 2012, the figure reached RMB3.86 billion, a year-on-year increase of 25.3%, of...

China Interventional Cardiovascular Device Industry Report, 2013-2015

With the accelerated aging, the prevalence of cardiovascular diseases in China increased year by year. According to statistics of National Health and Family Planning Commission of the People’s Republi...

China Diagnostic Reagent Industry Report, 2013-2015

Driven by huge population base, intensified aging and many favorable policies, China diagnostic reagent industry has been developing rapidly. In 2008-2012, the diagnostic reagent market size presented...

China Orthopedic Instrument Industry Report, 2013-2015

Benefiting from aging of population, consumption upgrade and policy support, China's orthopedic instrument industry has seen rapid development over the years, with total market size rising from 3.28 b...

China Ophthalmic Hospital Industry Report, 2012-2015

With the growing types of eye diseases and non-basic medical needs, China’s ophthalmic hospital industry has seen rapid development. In 2011, the number of ophthalmic hospitals in China reached 288, w...

China Chinese Patent Medicine Industry Report, 2012-2015

In recent years, China’s Chinese patent medicine industry has been running in good condition, with the revenue increasing from RMB 142 billion in 2008 to RMB 360 billion in 2012 at a CAGR of 26.2%. Ov...

2005-2014 All Rights Reserved 京ICP备05069564号-1 京公网安备1101054484号